Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition

Acute myeloid leukemia (AML) is an aggressive hematological malignancy with a dismal prognosis. The cytoplasmic spleen tyrosine kinase (SYK) is highly expressed by hematopoietic cells and has emerged as a potential therapeutic target. In this study, we evaluated the in vitro antileukemic effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Brattås, Marte Karen, Hemsing, Anette Lodvir, Rye, Kristin Paulsen, Hatfield, Kimberley Joanne, Reikvam, Håkon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737311/
https://www.ncbi.nlm.nih.gov/pubmed/36499034
http://dx.doi.org/10.3390/ijms232314706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737311/
https://www.ncbi.nlm.nih.gov/pubmed/36499034
http://dx.doi.org/10.3390/ijms232314706

Ejemplares similares